­
­
­
­

Inventi Impact: Pharmaceutical Process Development

Articles

  • Inventi:ppd/30754/19
    Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium \nConjugation Techniques
    Research 2020 : January - March
    Tivadar Feczko, Albrecht Piiper, Thomas Pleli, Christian Schmithals, Dominic Denk, Stephanie Hehlgans, Franz Rodel, Thomas J Vogl, Matthias G Wacker

    Today, efficient delivery of sorafenib to hepatocellular carcinoma remains a challenge for\ncurrent drug formulation strategies. Incorporating the lipophilic molecule into biocompatible and\nbiodegradable theranostic nanocarriers has great potential for improving the efficacy and safety of\ncancer therapy. In the present study, three different technologies for the encapsulation of sorafenib into poly���

    How to Cite this Article
    Attribution/ CC Compliant Citation: Feczko, Tivadar, et al. \"Theranostic Sorafenib-Loaded Polymeric Nanocarriers\nManufactured by Enhanced Gadolinium Conjugation Techniques.\" Pharmaceutics 11.10 (2019): 489.\nhttps://doi:10.3390/pharmaceutics11100489\nhttp://creativecommons.org/licenses/by/4.0/\n\nSome formatting elements, header, footer, logos, dates and pagination were modified while adapting this article.\n
    Download Full Text